Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guilong Dan Granules is a Traditional Chinese Medicine (TCM) formulation developed by The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine for the treatment of NIH category III chronic prostatitis (CP/CPPS). It is specifically indicated for patients presenting with the 'dampness heat and blood stasis' pattern, a common TCM syndrome in chronic prostatitis. The granules are composed of multiple herbal ingredients intended to clear heat, promote diuresis, and activate blood circulation to relieve pelvic pain and urinary symptoms. Clinical evaluation involves comparing the granules against Qianlie Shutong Capsules to assess improvements in the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) and safety profiles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guilong Dan Granules.